Atlas Trials

Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

9 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia

RecordFirmDate
CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell Malignancies (NCT05105867)920th Hospital of Joint Logistics Support Force of People's Liberation Army of China2021-09-29
CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma (NCT05054257)Institute of Hematology and Blood Transfusion, Czech Republic2021-06-02
BAFFR Targeting CAR-T Cells for the Treatment of Relapsed or Refractory B-cell ALL (NCT04690595)PeproMene Bio, Inc.2021-05-18
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (NCT04404660)Autolus Limited2020-06-03
CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL) (NCT04034446)Institute of Hematology & Blood Diseases Hospital, China2019-09-30
Pilot Study of Autologous Anti-CD22 Chimeric Antigen Receptor Redirected T Cells In Patients With Chemotherapy Resistant Or Refractory Acute Lymphoblastic Leukemia (NCT02588456)University of Pennsylvania2015-10-01
Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia (NCT02215629)Verastem, Inc.

Track Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia automatically

Every clearance here is in the API, with alerts when new ones post.